Your browser doesn't support javascript.
loading
Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast.
Ozsvari, Bela; Fiorillo, Marco; Bonuccelli, Gloria; Cappello, Anna Rita; Frattaruolo, Luca; Sotgia, Federica; Trowbridge, Rachel; Foster, Richard; Lisanti, Michael P.
Affiliation
  • Ozsvari B; Translational Medicine, School of Environment & Life Sciences, University of Salford, Greater Manchester, UK.
  • Fiorillo M; The Paterson Institute, University of Manchester, Withington, UK.
  • Bonuccelli G; Translational Medicine, School of Environment & Life Sciences, University of Salford, Greater Manchester, UK.
  • Cappello AR; The Paterson Institute, University of Manchester, Withington, UK.
  • Frattaruolo L; The Department of Pharmacy, Health and Nutritional Sciences, The University of Calabria, Cosenza, Italy.
  • Sotgia F; Translational Medicine, School of Environment & Life Sciences, University of Salford, Greater Manchester, UK.
  • Trowbridge R; The Paterson Institute, University of Manchester, Withington, UK.
  • Foster R; The Department of Pharmacy, Health and Nutritional Sciences, The University of Calabria, Cosenza, Italy.
  • Lisanti MP; The Department of Pharmacy, Health and Nutritional Sciences, The University of Calabria, Cosenza, Italy.
Oncotarget ; 8(40): 67457-67472, 2017 Sep 15.
Article in En | MEDLINE | ID: mdl-28978045
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: United kingdom Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: United kingdom Country of publication: United States